We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

2020-08-07T18:51:52-04:00